AN2690, 2.5%

DRUG2 trials

Sponsors

Pfizer

Conditions

Distal, Subungual Onychomycosis

Phase 2

Study of Different Doses of a Novel Treatment for Onychomycosis

CompletedNCT00679965

PfizerDistal, Subungual Onychomycosis

Start: 2006-02-28End: 2007-07-31Updated: 2018-12-12

Study of Different Doses of a Novel Treatment for Onychomycosis

CompletedNCT00679770

PfizerDistal, Subungual Onychomycosis

Start: 2006-06-30End: 2007-08-31Updated: 2018-02-20